The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II clinical trial of cisplatin/carboplatin and etoposide (CE) alone or in combination with nivolumab as frontline therapy for extensive-stage small cell lung cancer (ES-SCLC): ECOG-ACRIN EA5161.
 
Ticiana Leal
No Relationships to Disclose
 
Yating Wang
No Relationships to Disclose
 
Afshin Dowlati
No Relationships to Disclose
 
DeQuincy Andrew Lewis
No Relationships to Disclose
 
Yuanbin Chen
No Relationships to Disclose
 
Amit Ramesh Mohindra
No Relationships to Disclose
 
Mohammad Razaq
No Relationships to Disclose
 
Harish G. Ahuja
No Relationships to Disclose
 
Jijun Liu
No Relationships to Disclose
 
David M. King
No Relationships to Disclose
 
Christopher Joseph Sumey
No Relationships to Disclose
 
Suresh S. Ramalingam
No Relationships to Disclose